Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (11188)	7/10/1998 9:08:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

blankmind, The promise of MUSE gave Vivus a $15 to $20 stock price before its approval. Now that we have Alibra AND a genetic therapy drug does that mean we will soon be a $26 stock? Quick! Get out the horns and call CNBC.....a new drug better than Viagra......another ICOS in the making.......should be good for a 10 point run. But wait. Vivus doesnt know how to pimp or hype its future products so maybe we again will have to help them out a little on the PR end.